The Venture Codex

Participated · Seed · Nov 2025

Red Queen Bio is a newly launched company spun out of HelixNano that focuses on "scaling biological defenses" as artificial intelligence capabilities accelerate. The firm’s platform combines state-of-the-art AI models with lab automation and reinforcement learning to systematically map potential AI-enabled biothreats. Using those insights, the company intends to design and stockpile medical countermeasures in advance of possible outbreaks. The founders emphasize that the scientific work begins with the close of the seed financing, indicating the company is still pre-commercial. No revenue, user, or other operating metrics have been disclosed. The overall vision positions Red Queen Bio at the intersection of synthetic biology, machine learning, and public health preparedness.